Aleva Neurotherapeutics SA
Developing next-generation implants for Deep Brain Stimulation (DBS) therapy.
Alpex Pharma SA
Contract manufacturing and formulation of drugs and food supplements.
AM Pharma BV
Developing alkaline phosphatase as treatment for severe inflammatory conditions.
Hyaluronic-based products for aesthetic medicine and other medical use (acquired by Merz Pharma).
Atlas Genetics Ltd
Developing point-of-care diagnostic devices.
Cadence Pharmaceuticals, Inc.
Specialty therapeutics for hospitals (publicly listed, later acquired by Mallinckrodt).
Calypso Medical Technologies, Inc.
Tumor localisation systems (acquired by Varian).
Cameron Health, Inc.
Subcutaneous implantable cardio defibrillators (acquired by Boston Scientific).
Molecular Partners AG
Development of DARPIN based therapeutics (publicly listed: MOLN).
Neose Technologies Inc.
Next generation biotherapeutics (asset sale to Teva and Novo Nordisk.
Natural dental implants AG
Minimally invasive dental implants for single tooth replacement.
Intracorneal lenses for the treatment of presbyopia (asset sale to Presbia, Inc.).
Optimer Pharmaceuticals, Inc.
Anti-infective therapeutics (publicly listed, later acquired by Cubist, now Merck).
Opsona Therapeutics Ltd
Developing TLR agonists for the treatment of inflammatory conditions and cancer.
Orthocon, Inc. (now Abyrx, Inc.)
Radius Health, Inc.
Developing therapeutics for osteoporosis and other serious endocrine mediated diseases (publicly listed: RDUS.
Swiss Smile AG
Dental clinics chain.
Small molecule kinase inhibitors to treat cancer (acquired by Sanofi).
Tioga Pharmaceuticals, Inc.
Developing therapeutics for the treatment of pruritus.
Developing cancer immuno-therapeutics.